Protocol LAM 20007: "An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of Lamictal in Pediatric Subjects Who Have Previously Taken Part in Study LAM20006"

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/00 → 4/30/07

Funding

  • Glaxo Wellcome: $41,499.00